Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic ...

In a new study, researchers have identified a way to stop cells from dying, opening the door to developing treatments that slow the progression of neurodegenerative conditions like Parkinson’s ...

Congenital heart disease is a leading cause of death in newborns, yet many of its molecular mechanisms remain unknown. Both maternal obesity and diabetes increase the risk of congenital heart disease ...

The project will study the structure and function of temperature-sensitive proteins in animals adapted to different thermal environments, such as the woolly mammoth, the polar bear, and the Asian ...

Recently, the innovation team of Cucurbitaceae Vegetable Genetics and Breeding at Institute of Vegetables and Flowers (IVF, CAAS) made important progress in molecular mechanism of powdery mildew ...

Scientists have discovered a new way to destroy cancer cells. Stimulating aminocyanine molecules with near-infrared light caused them to vibrate in sync, enough to break apart the membranes of cancer ...

Antidepressant prescriptions continue to steadily grow in England As quarterly antidepressant prescriptions hit 22 million, the NHS looks to cut down patient reliance.

Halda Therapeutics, based in New Haven, Connecticut, is developing a new class of therapies called regulated induced proximity targeting chimeras (RIPTACs) to treat cancer. The company, with $76 ...

ETH scientists have generated a huge true random number using DNA synthesis. It is the first time that a number of this magnitude has been created by biochemical means.